Geode Capital Management’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $239K | Sell |
213,273
-212,387
| -50% | -$238K | ﹤0.01% | 3817 |
|
|
2025
Q1 | $490K | Buy |
425,660
+16,527
| +4% | +$19K | ﹤0.01% | 3552 |
|
|
2024
Q4 | $2.5M | Buy |
409,133
+13,334
| +3% | +$81.5K | ﹤0.01% | 3051 |
|
|
2024
Q3 | $6.55M | Buy |
395,799
+28,118
| +8% | +$465K | ﹤0.01% | 2611 |
|
|
2024
Q2 | $2.53M | Buy |
367,681
+31,676
| +9% | +$218K | ﹤0.01% | 3055 |
|
|
2024
Q1 | $3.24M | Buy |
336,005
+9,349
| +3% | +$90.2K | ﹤0.01% | 2914 |
|
|
2023
Q4 | $2.71M | Buy |
326,656
+34,124
| +12% | +$284K | ﹤0.01% | 2991 |
|
|
2023
Q3 | $2.44M | Buy |
292,532
+72,115
| +33% | +$602K | ﹤0.01% | 3004 |
|
|
2023
Q2 | $2.03M | Buy |
220,417
+22,360
| +11% | +$206K | ﹤0.01% | 3112 |
|
|
2023
Q1 | $2.72M | Buy |
198,057
+4,307
| +2% | +$59.2K | ﹤0.01% | 2907 |
|
|
2022
Q4 | $3.3M | Buy |
193,750
+10,735
| +6% | +$183K | ﹤0.01% | 2864 |
|
|
2022
Q3 | $4.16M | Sell |
183,015
-13,695
| -7% | -$311K | ﹤0.01% | 2764 |
|
|
2022
Q2 | $3.55M | Sell |
196,710
-17,572
| -8% | -$317K | ﹤0.01% | 2885 |
|
|
2022
Q1 | $5.73M | Buy |
214,282
+69,101
| +48% | +$1.85M | ﹤0.01% | 2721 |
|
|
2021
Q4 | $4.26M | Sell |
145,181
-8,218
| -5% | -$241K | ﹤0.01% | 2985 |
|
|
2021
Q3 | $10.1M | Buy |
153,399
+8,390
| +6% | +$552K | ﹤0.01% | 2448 |
|
|
2021
Q2 | $12.1M | Buy |
145,009
+8,943
| +7% | +$744K | ﹤0.01% | 2328 |
|
|
2021
Q1 | $10.4M | Buy |
136,066
+17,340
| +15% | +$1.33M | ﹤0.01% | 2332 |
|
|
2020
Q4 | $10.5M | Sell |
118,726
-1,492
| -1% | -$132K | ﹤0.01% | 2145 |
|
|
2020
Q3 | $8.87M | Sell |
120,218
-40,685
| -25% | -$3M | ﹤0.01% | 2016 |
|
|
2020
Q2 | $11.7M | Buy |
160,903
+9,384
| +6% | +$685K | ﹤0.01% | 1840 |
|
|
2020
Q1 | $8.51M | Buy |
151,519
+28,965
| +24% | +$1.63M | ﹤0.01% | 1842 |
|
|
2019
Q4 | $4.68M | Buy |
+122,554
| New | +$4.68M | ﹤0.01% | 2498 |
|